»
Antikörper
»
anti-Hepatitis B Core Antigen (HBcAg) Antikörper
Hepatitis B Core Antigen (HBcAg) Antikörper
| Antigen |
|
| Klonalität |
Polyklonal |
|
Wirt
|
|
|
Reaktivität
|
|
|
Applikation
|
Enzyme Immunoassay (EIA) (38), Western Blot (WB) (28), Immunhistochemie (Gefrierschnitte) (IHC (fro)) (27), Immunpräzipitation (IP) (21), Immunhistochemie (Paraffinschnitte) (IHC (p)) (12), Immunfluoreszenz (IF) (11), ELISA (8), Durchflusszytometrie (FACS) (8), ELISA (Detektionsantikörper) (4), ELISA (Fangantikörper) (2), Immunoelectron Microscopy (IEM) (1), Immunhistochemie (formalinfixierte Schnitte) (IHC (f)) (1), Immunhistochemie (IHC) (1)
|
| Produktnummer |
ABIN197704 |
| Menge |
0.5 ml (100ug/ml approximately) (Varianten) |
| Preis |
97,12 € Zzgl. Versandkosten €40,00 und MWSt
|
| Lieferung nach |
|
| Verfügbarkeit |
Lieferung in 5 Werktagen |
|
Immunogen
|
HBcAg purified from the lysates of E. coli infected with the viral core DNA.
|
|
Format
|
Concentrated
|
|
Spezifität
|
This antigen reacts in the nuclei of the liver cells of the Hepatitis type B virus infected patients. However, occasional staining may also be seen in the perinuclear cytoplasm of the infected cells.
|
|
Applikationshinweise
|
Titer/Working Dilution: This antibody may be diluted to a titer of 1:50-1:150 in an ABC method. However, depending on the staining conditions employed, we suggest that final dilution should be determined by the user. Staining Protocol: We suggest an incubation period of 30 minutes at room temperature. However, depending upon the fixation conditions and the staining system employed, optimal incubation conditions should be determined by the user. Suitable for formalin/paraffin tissues. Positive Control: Infected liver. Cellular localization: Nuclear
|
|
Konzentration
|
100ug/ml approximately
|
|
Buffer
|
Whole rabbit antiserum containing sodium azide as preservative.
|
|
Lagerung
|
Store the antibody at 2-8o c. Do not use it beyond the expiration date stated on the label.
|
|
Beschränkungen
|
Für Forschungszwecke. Als CE-zertifizierter Antikörper in der Europäischen Union für In Vitro Diagnostik (IVD) zugelassen.
|
|
Publikationen
|
Riedl, Wieland, Lamberth et al.: "Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 183, Issue 1, pp. 370-80, 2009 (PubMed).
|
Alternativen zu Antigen "Hepatitis B Core Antigen (HBcAg)", Typ "Antikörper" finden
|
Wirte
|
Maus (53), Kaninchen (13)
|
|
Reaktivitäten
|
Hepatitis B (HBV) (8), Human (4)
|
|
Applikationen
|
Enzyme Immunoassay (EIA) (38), Western Blot (WB) (28), Immunhistochemie (Gefrierschnitte) (IHC (fro)) (27), Immunpräzipitation (IP) (21), Immunhistochemie (Paraffinschnitte) (IHC (p)) (12), Immunfluoreszenz (IF) (11), ELISA (8), Durchflusszytometrie (FACS) (8), ELISA (Detektionsantikörper) (4), ELISA (Fangantikörper) (2), Immunoelectron Microscopy (IEM) (1), Immunhistochemie (formalinfixierte Schnitte) (IHC (f)) (1), Immunhistochemie (IHC) (1)
|
|
Konjugate
|
Biotin (2), HRP (1)
|
|
Epitope
|
ayw (5), AA 1-10 N-Term End (1), ayw AA 130-140 (1), ayw AA 138-145 (1)
|